Found: 25
Select item for more details and to access through your institution.
Assessing the Functional Redundancy between P-gp and BCRP in Controlling the Brain Distribution and Biliary Excretion of Dual Substrates with PET Imaging in Mice.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 8, p. 1286, doi. 10.3390/pharmaceutics13081286
- By:
- Publication type:
- Article
Imaging-Based Characterization of a Slco2b1 (-/-) Mouse Model Using [ 11 C]Erlotinib and [ 99m Tc]Mebrofenin as Probe Substrates.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 6, p. 918, doi. 10.3390/pharmaceutics13060918
- By:
- Publication type:
- Article
Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [99mTc]mebrofenin Imaging in Rats.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 6, p. 486, doi. 10.3390/pharmaceutics12060486
- By:
- Publication type:
- Article
Pharmacokinetic Imaging Using 99m Tc-Mebrofenin to Untangle the Pattern of Hepatocyte Transporter Disruptions Induced by Endotoxemia in Rats.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 4, p. N.PAG, doi. 10.3390/ph15040392
- By:
- Publication type:
- Article
Use of PET Imaging to Assess the Efficacy of Thiethylperazine to Stimulate Cerebral MRP1 Transport Activity in Wild-Type and APP/PS1-21 Mice.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 12, p. 6514, doi. 10.3390/ijms23126514
- By:
- Publication type:
- Article
Influence of Cation Transporters (OCTs and MATEs) on the Renal and Hepatobiliary Disposition of [11C]Metoclopramide in Mice.
- Published in:
- Pharmaceutical Research, 2021, v. 38, n. 1, p. 127, doi. 10.1007/s11095-021-03002-2
- By:
- Publication type:
- Article
Towards Improved Pharmacokinetic Models for the Analysis of Transporter-Mediated Hepatic Disposition of Drug Molecules with Positron Emission Tomography.
- Published in:
- AAPS Journal, 2019, v. 21, n. 4, p. 1, doi. 10.1208/s12248-019-0323-0
- By:
- Publication type:
- Article
[ 11 C]metoclopramide is a sensitive radiotracer to measure moderate decreases in P-glycoprotein function at the blood-brain barrier.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2024, v. 44, n. 1, p. 142, doi. 10.1177/0271678X231202336
- By:
- Publication type:
- Article
Complete inhibition of ABCB1 and ABCG2 at the blood–brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [ 11 C]erlotinib.
- Published in:
- Journal of Cerebral Blood Flow & Metabolism, 2021, v. 41, n. 7, p. 1634, doi. 10.1177/0271678X20965500
- By:
- Publication type:
- Article
Repurposing 99mTc‐mebrofenin as a probe for molecular imaging of hepatocyte transporters.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.261321
- By:
- Publication type:
- Article
Repurposing 99mTc‐mebrofenin as a probe for molecular imaging of hepatocyte transporters.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.261321
- By:
- Publication type:
- Article
Repurposing <sup>99m</sup>Tc‐mebrofenin as a probe for molecular imaging of hepatocyte transporters.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.261321
- By:
- Publication type:
- Article
Repurposing <sup>99m</sup>Tc‐mebrofenin as a probe for molecular imaging of hepatocyte transporters.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.261321
- By:
- Publication type:
- Article
Repurposing <sup>99m</sup>Tc-mebrofenin as a probe for molecular imaging of hepatocyte transporters.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.261321
- By:
- Publication type:
- Article
Repurposing <sup>99m</sup>Tc-mebrofenin as a probe for molecular imaging of hepatocyte transporters.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.261321
- By:
- Publication type:
- Article
Repurposing <sup>99m</sup>Tc-mebrofenin as a probe for molecular imaging of hepatocyte transporters.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.120.261321
- By:
- Publication type:
- Article
Repurposing <sup>99m</sup>Tc-mebrofenin as a probe for molecular imaging of hepatocyte transporters.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.261321
- By:
- Publication type:
- Article
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.244038
- By:
- Publication type:
- Article
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.244038
- By:
- Publication type:
- Article
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.244038
- By:
- Publication type:
- Article
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.244038
- By:
- Publication type:
- Article
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.244038
- By:
- Publication type:
- Article
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.120.244038
- By:
- Publication type:
- Article
Assessing the Activity of Multidrug Resistance-Associated Protein 1 at the Lung Epithelial Barrier.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.120.244038
- By:
- Publication type:
- Article
St. John's wort extract with a high hyperforin content does not induce P‐glycoprotein activity at the human blood–brain barrier.
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 5, p. 1, doi. 10.1111/cts.13804
- By:
- Publication type:
- Article